Home - Products - Others - Other Targets - Isorhamnetin 3-glucoside-7-rhamnoside

Isorhamnetin 3-glucoside-7-rhamnoside

CAS No. 17331-71-4

Isorhamnetin 3-glucoside-7-rhamnoside( —— )

Catalog No. M31401 CAS No. 17331-71-4

An anti-oxidative composition containing isorhamnetin-3-glucoside-7-rhamnoside (IGR)isolated from Hippophae rhamnoides L. is provided to ensure antioxidative, antibacterial, and anti-cancer effect.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 574 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    Isorhamnetin 3-glucoside-7-rhamnoside
  • Note
    Research use only, not for human use.
  • Brief Description
    An anti-oxidative composition containing isorhamnetin-3-glucoside-7-rhamnoside (IGR)isolated from Hippophae rhamnoides L. is provided to ensure antioxidative, antibacterial, and anti-cancer effect.
  • Description
    An anti-oxidative composition containing isorhamnetin-3-glucoside-7-rhamnoside (IGR)isolated from Hippophae rhamnoides L. is provided to ensure antioxidative, antibacterial, and anti-cancer effect.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    17331-71-4
  • Formula Weight
    624.54
  • Molecular Formula
    C28H32O16
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • BR-1

    BR-1 is a phosphatase of regenerating liver 3 (PRL-3) inhibitor which blocks the migration and invasion of metastatic cancer cells.

  • Methyl (E)-sinapate

    Methyl (E)-sinapate is isolated from the Polygala sibirica L.var. megalopha Fr.

  • Brilliant Blue FCF

    Brilliant blue FCF is a nontoxic dye for saphenous vein graft marking that abrogates response to injury.